Cantor JH, Whaley CM, Stein BD, Powell D (2022) Analysis of substance use disorder treatment admissions in the US by sex and race and ethnicity before and during the COVID-19 pandemic. JAMA Net Open 5:e2232795
Hunt GE, Large MM, Cleary M, Lai HMX, Saunders JB (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: systematic review and meta-analysis. Drug Alcohol Depend 191:234–258
Roncero C, García-Ullán L, Bullón A, Remón-Gallo D, Vicente-Hernández B, Álvarez A, Caldero A, Flores A, Aguilar L (2020) The relevance of dual diagnoses among drug-dependent patients with sleep disorders. J Clin Med 9:2862
Article PubMed PubMed Central Google Scholar
Río-Martínez L, Marquez-Arrico JE, Prat G, Adan A (2020) Temperament and character profile and its clinical correlates in male patients with dual schizophrenia. J Clin Med 9:1–16
Lynn Starr H, Bermak J, Mao L, Rodriguez S, Alphs L (2018) Comparison of longacting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: an exploratory analysis of the PRIDE study. Schizophr Res 194:39–46
Article CAS PubMed Google Scholar
Togay B, Noyan H, Tasdelen R, Ucok A (2015) Clinical variables associated with suicide attempts in schizophrenia before and after the first episode. Psychiatr Res 229:252–256
Donoghue K, Doody GA, Murray RM, Jones PB, Morgan C, Dazzan P, Hart J, Mazzonicini R, MacCabe JH (2014) Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study. Psychiatry Res 215:528–532
Cambras T, Díez-Noguera A (2018) The social role of chronobiology. Biol Rhythm Res 50:18–27
Adan A, Archer SN, Hidalgo MP, Di Milia L, Natale V, Randler C (2012) Circadian typology: a comprehensive review. Chronobiol Int 29:1153–1175
Suh S, Yang HC, Kim N, Yu JH, Choi S, Yun CH, Shin C (2019) Chronotype differences in health behaviors and health-related quality of life: a population-based study among aged and alder adults. Behav Sleep Med 15:361–376
Mullington JM, Abbott SM, Carroll JE, Davis CJ, Dijk DJ, Dinges DF, Gehrman PR, Gozal D, Haack M, Lim DC, Macrea M, Pack AI, Plante DT, Teske JA, ZeePC (2016) Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep 39:727–736
Article PubMed PubMed Central Google Scholar
Ortiz-Tudela E, Martinez-Nicolas A, Albares J, Segarra F, Campos M, Estivill E, Rol MA, Madrir JA (2014) Ambulatory circadian monitoring (ACM) based on thermometry, motor activity and body position (TAP): a comparison with polysomnography. Physiol Behav 126:30–38
Article CAS PubMed Google Scholar
Martinez-Nicolas A, Martinez-Madrid MJ, Almaida-Pagan PF, Bonmati-Carrion MA, Madrid JA, Rol MA (2019) Assessing chronotypes by ambulatory circadian monitoring. Front Physiol 10:1396
Article PubMed PubMed Central Google Scholar
Bonmati-Carrion MA, Middleton B, Revell V, Skene DJ, Rol MA, Madrid JA (2014) Circadian phase asessment by ambulatory monitoring in humans: correlation with dim light melatonin onset. Chronobiol Int 31:37–51
Article CAS PubMed Google Scholar
Prosser RA, Stowie A, Amicarelli M, Nackenoff AG, Blakely RD, Glass JD (2014) Cocaine modulates mammalian circadian clock timing by decreasing serotonin transport in the SCN. Neuroscience 275:184–193
Article CAS PubMed Google Scholar
Capella MM, Martinez-Nicolas A, Adan A (2018) Circadian rhythmic characteristics in men with substance use disorder under treatment. Influence of age of onset of substance use and duration of abstinence. Front Psychiatr 9:1–13
Laskemoen JF, Simonsen C, Büchmann C, Barrett EA, Bjella T, Lagerberg TV, Vedal TJ, Andreassen OA, Melle I, Aas M (2019) Sleep disturbances in schizophrenia spectrum and bipolar disorders—a transdiagnostic perspective. Compr Psychiatr 91:6–12
Løberg EM, Nygård M, Berle JØ, Johnsen E, Kroken RA, Jørgensen HA, Hugdal K (2012) An fMRI study of neuronal activation in schizophrenia patients with and without previous cannabis use. Front Psychiatr 3:1–11
Kaskie RE, Graziano B, Ferrarelli F (2017) Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep 9:227–239
Article PubMed PubMed Central Google Scholar
Robertson I, Cheung A, Fan X (2019) Insomnia in patients with schizophrenia: current understanding and treatment options. Prog Neuro-Psychopharmacol Biol Psychiatr 92:235–242
Coulon L, Brailly-Tabard S, Walter M, Tordjman S (2016) Altered circadian patterns of salivary cortisol in individuals with schizophrenia: a critical literature review. J Physiol Paris 110:439–447
Lamont EW, Coutu DL, Cermakian N, Boivin DB (2010) Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Relat Sci 47:27–33
Chung KF, Poon YPYP, Ng TK, Kan CK (2018) Correlates of sleep irregularity in schizophrenia. Psychiatry Res 270:705–714
Manoach DS, Pan JQ, Purcell SM, Stickgold R (2016) Reduced sleep spindles in schizophrenia: a treatable endophenotype that links risk genes to impaired cognition? Biol Psychiatr 80:599–608
Serrano-Serrano AB, Marquez-Arrico JE, Navarro JF, Martinez-Nicolas A, Adan A (2021) Circadian characteristics in patients under treatment for substance use disorders and severe mental illness (schizophrenia, major depression and bipolar disorder). J Clin Med 10:4388
Article PubMed PubMed Central Google Scholar
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Inc, Washington
Horn WT, Akerman SC, Sateia MJ (2013) Sleep in schizophrenia and substance use disorders: a review of the literature. J Dual Diag 9:228–238
First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I disorders, research version, patient edition (SCID-I/P). Biometrics research. New York State Psychiatric Institute, New York
Gálvez BP, Fernández LG (2010) Validación española del drug abuse screening test (DAST-20 y DAST-10). Heal Addict 10:35–50
Peralta V, Cuesta MJ (1994) Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Luso-Españolas Neurolología, Psiquiatr y Ciencias Afines 22:171–177
Adan A, Caci H, Prat G (2005) Reliability of the Spanish version of the composite scale of morningness. Eur Psychiatr 20:503–509
Martinez-Nicolas A, Madrid JA, Rol MA (2014) Day-night contrast as source of health for the human circadian system. Chronobiol Int 31:382–393
Sosa M, Mondéjar MT, Martinez-Nicolas A, Ortiz-Tudela E, Sarabia JA, Sosa J, Otalora B, Rol MA, Madrid JA, Campos M, Marín M. Circadianware. Spanish Patent 08/2010/183, 3 September 2010
Jonasdottir SS, Minor K, Lehmann S (2021) Gender differences in nighttime sleep patterns and variability across the adult lifespan: a global-scale wearables study. Sleep 44:1–16
Van Someren EJW, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB (1999) Bright light therapy: improved rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int 16:505–518
Jankowski KS (2015) Composite scale of morningness: psychometric properties, validity with Munich chronotype questionnaire and age/sex differences in Poland. Eur Psychiatr 30:166–171
Castro J, Zanini M, Gonçalves Bda S, Coelho FM, Bressan R, Bittencourt L, Gadelha A, Brietzke E, Tufik S (2015) Circadian rest-activity rhythm in individuals at risk for psychosis and bipolar disorder. Schizophr Res 168:50–55
Prom-Wormley EC, Ebejer J, Dick DM, Bowers MS (2017) The genetic epidemiology of substance use disorder: a review. Drug Alcohol Depend 180:241–259
Article PubMed PubMed Central Google Scholar
Benaiges I, Serra-Grabulosa JM, Adan A (2013) Neuropsychological functioning and age-related changes in schizophrenia and/or cocaine dependence. Prog Neuropsychopharmacol Biol Psychiatr 40:298–305
Marquez-Arrico JE, Benaiges I, Adan A (2015) Strategies to cope with treatment in substance use disorder male patients with and without schizophrenia. Psychiatry Res 228:752–759
Sofin Y, Danker-Hopfe H, Gooren T, Neu P (2017) Predicting inpatient detoxification outcome of alcohol and drug dependent patients: the influence of sociodemographic environment, motivation, impulsivity, and medical comorbidities. J Addict 2017:1–11
Belbasis L, Köhler CA, Stefanis N, Stubbs B, van Os J, Vieta E, Seeman MV, Arango C, Carvahlo AF, Evangelou E (2018) Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr Scand 137:88–97
Article CAS PubMed Google Scholar
Adan A, Arredondo AY, Capella MD, Prat G, Forero DA, Navarro JF (2017) Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: a systematic review. Neurosci Biobehav Rev 65:361–377
Antúnez JM, Capella MM, Navarro JF, Adan A (2016) Circadian rhythmicity in substance use disorder male patients with and without comorbid depression under ambulatory and therapeutic community treatment. Chronobiol Int 3
留言 (0)